Charles River Laboratories International, Inc. (CRL) vs Guardant Health, Inc. (GH)
- Charles River Laboratories International, Inc. CRL 299.77 −2.11%
- Guardant Health, Inc. GH 158.29 −4.58%
Charles River Laboratories International, Inc. and Guardant Health, Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $22.3B against $14.6B — 1.5× the size. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against −0.74%. Charles River Laboratories International, Inc. has the higher net margin (−5.96% vs −38.3%) and the higher return on invested capital (1.07% vs −129.7%). Across the 17 metrics below, Charles River Laboratories International, Inc. leads on 9 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | CRL | GH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 32.67% | 65.01% | 50.89% |
| Operating margin | 2.25% | (39.75%) | (8.57%) |
| Net margin | (5.96%) | (38.33%) | (6.37%) |
| Free cash flow margin | 9.27% | (20.35%) | 0.00% |
| Return on equity | (7.69%) | 171.64% | (2.92%) |
| Return on assets | (3.16%) | (27.95%) | (6.71%) |
| Return on invested capital | 1.07% | (129.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack